RE:RE:BABY STEPSDisagree. The operating expenses in Q1 were $1.7 million. Assuming they stay close to that and revenue is similar from covid of around $2-2.5 million and the start of revenue for Aristotle and they will be profitable. Factor in that the warrants and debentures will be a favorable adjustment given the lower share porice and higher Canadian dollar and we could see the first profitable and positive quarter. Financials come out Aug 16 so even a slight delay on the Care Oncology deal and it should still close before Q2 is reported.
So we could see a positive EBITDA, a positive warrant valuation and a closed deal.
frewil11 wrote: The market will not like Q2 results one bit , it is good that the company will have brought in good revenue from Covid testing but it will be zero from aristotle wich the market will not like .